 | • レポートコード：GIR201107565 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、人工関節感染症（PJI）治療の世界市場を調査対象にし、人工関節感染症（PJI）治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Cempra Inc、Telephus Medical LLC、Motif Bio Plc、Nabriva Therapeutics AG、TenNor Therapeutics Ltd ・メーカー別販売量、売上、市場シェア ・人工関節感染症（PJI）治療の地域別市場分析 ・人工関節感染症（PJI）治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・人工関節感染症（PJI）治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・人工関節感染症（PJI）治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・人工関節感染症（PJI）治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・人工関節感染症（PJI）治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・人工関節感染症（PJI）治療の種類別市場規模2015-2020：フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他 ・人工関節感染症（PJI）治療の用途別市場規模2015-2020：病院、クリニック、その他 ・人工関節感染症（PJI）治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Prosthetic Joint Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prosthetic Joint Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prosthetic Joint Infections Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prosthetic Joint Infections Treatment market has been segmented into
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others
By Application, Prosthetic Joint Infections Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prosthetic Joint Infections Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Prosthetic Joint Infections Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prosthetic Joint Infections Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Prosthetic Joint Infections Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prosthetic Joint Infections Treatment Market Share Analysis
Prosthetic Joint Infections Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prosthetic Joint Infections Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prosthetic Joint Infections Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Prosthetic Joint Infections Treatment are:
Cempra Inc
Telephus Medical LLC
Motif Bio Plc
Nabriva Therapeutics AG
TenNor Therapeutics Ltd
Among other players domestic and global, Prosthetic Joint Infections Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prosthetic Joint Infections Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prosthetic Joint Infections Treatment, with price, sales, revenue and global market share of Prosthetic Joint Infections Treatment in 2018 and 2019.
Chapter 3, the Prosthetic Joint Infections Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prosthetic Joint Infections Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prosthetic Joint Infections Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prosthetic Joint Infections Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Prosthetic Joint Infections Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prosthetic Joint Infections Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Fusidic acid
1.2.3 Lefamulin Acetate
1.2.4 MTF-101
1.2.5 TNP-2092
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prosthetic Joint Infections Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Prosthetic Joint Infections Treatment Market
1.4.1 Global Prosthetic Joint Infections Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cempra Inc
2.1.1 Cempra Inc Details
2.1.2 Cempra Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cempra Inc SWOT Analysis
2.1.4 Cempra Inc Product and Services
2.1.5 Cempra Inc Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Telephus Medical LLC
2.2.1 Telephus Medical LLC Details
2.2.2 Telephus Medical LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Telephus Medical LLC SWOT Analysis
2.2.4 Telephus Medical LLC Product and Services
2.2.5 Telephus Medical LLC Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Motif Bio Plc
2.3.1 Motif Bio Plc Details
2.3.2 Motif Bio Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Motif Bio Plc SWOT Analysis
2.3.4 Motif Bio Plc Product and Services
2.3.5 Motif Bio Plc Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nabriva Therapeutics AG
2.4.1 Nabriva Therapeutics AG Details
2.4.2 Nabriva Therapeutics AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nabriva Therapeutics AG SWOT Analysis
2.4.4 Nabriva Therapeutics AG Product and Services
2.4.5 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 TenNor Therapeutics Ltd
2.5.1 TenNor Therapeutics Ltd Details
2.5.2 TenNor Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 TenNor Therapeutics Ltd SWOT Analysis
2.5.4 TenNor Therapeutics Ltd Product and Services
2.5.5 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prosthetic Joint Infections Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prosthetic Joint Infections Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prosthetic Joint Infections Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Prosthetic Joint Infections Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Prosthetic Joint Infections Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prosthetic Joint Infections Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
4.5 South America Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Prosthetic Joint Infections Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Prosthetic Joint Infections Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Prosthetic Joint Infections Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prosthetic Joint Infections Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
6.3 UK Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
6.4 France Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prosthetic Joint Infections Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prosthetic Joint Infections Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7.5 India Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Prosthetic Joint Infections Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Prosthetic Joint Infections Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prosthetic Joint Infections Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prosthetic Joint Infections Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prosthetic Joint Infections Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prosthetic Joint Infections Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Prosthetic Joint Infections Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Prosthetic Joint Infections Treatment Price by Type (2015-2020)
11 Global Prosthetic Joint Infections Treatment Market Segment by Application
11.1 Global Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
11.2 Global Prosthetic Joint Infections Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Prosthetic Joint Infections Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prosthetic Joint Infections Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Prosthetic Joint Infections Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Prosthetic Joint Infections Treatment Market Forecast (2021-2025)
12.2.2 Europe Prosthetic Joint Infections Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prosthetic Joint Infections Treatment Market Forecast (2021-2025)
12.2.4 South America Prosthetic Joint Infections Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prosthetic Joint Infections Treatment Market Forecast (2021-2025)
12.3 Prosthetic Joint Infections Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Prosthetic Joint Infections Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Prosthetic Joint Infections Treatment Market Share Forecast by Type (2021-2025)
12.4 Prosthetic Joint Infections Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Prosthetic Joint Infections Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Prosthetic Joint Infections Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prosthetic Joint Infections Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prosthetic Joint Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prosthetic Joint Infections Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cempra Inc Basic Information, Manufacturing Base and Competitors
Table 8. Cempra Inc Prosthetic Joint Infections Treatment Major Business
Table 9. Cempra Inc Prosthetic Joint Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 10. Cempra Inc SWOT Analysis
Table 11. Cempra Inc Prosthetic Joint Infections Treatment Product and Services
Table 12. Cempra Inc Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Telephus Medical LLC Basic Information, Manufacturing Base and Competitors
Table 14. Telephus Medical LLC Prosthetic Joint Infections Treatment Major Business
Table 15. Telephus Medical LLC Prosthetic Joint Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 16. Telephus Medical LLC SWOT Analysis
Table 17. Telephus Medical LLC Prosthetic Joint Infections Treatment Product and Services
Table 18. Telephus Medical LLC Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Motif Bio Plc Basic Information, Manufacturing Base and Competitors
Table 20. Motif Bio Plc Prosthetic Joint Infections Treatment Major Business
Table 21. Motif Bio Plc Prosthetic Joint Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 22. Motif Bio Plc SWOT Analysis
Table 23. Motif Bio Plc Prosthetic Joint Infections Treatment Product and Services
Table 24. Motif Bio Plc Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Nabriva Therapeutics AG Basic Information, Manufacturing Base and Competitors
Table 26. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Major Business
Table 27. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 28. Nabriva Therapeutics AG SWOT Analysis
Table 29. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Product and Services
Table 30. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. TenNor Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 32. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Major Business
Table 33. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 34. TenNor Therapeutics Ltd SWOT Analysis
Table 35. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Product and Services
Table 36. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Prosthetic Joint Infections Treatment Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Prosthetic Joint Infections Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Prosthetic Joint Infections Treatment Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Prosthetic Joint Infections Treatment Sales Market Share by Regions (2015-2020)
Table 41. Global Prosthetic Joint Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Prosthetic Joint Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Prosthetic Joint Infections Treatment Sales Market Share by Countries (2015-2020)
Table 44. North America Prosthetic Joint Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 46. Europe Prosthetic Joint Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Prosthetic Joint Infections Treatment Sales Market Share by Countries (2015-2020)
Table 48. Europe Prosthetic Joint Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Prosthetic Joint Infections Treatment Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Prosthetic Joint Infections Treatment Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Prosthetic Joint Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Prosthetic Joint Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Prosthetic Joint Infections Treatment Sales Market Share by Countries (2015-2020)
Table 54. South America Prosthetic Joint Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Prosthetic Joint Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Prosthetic Joint Infections Treatment Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Prosthetic Joint Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 60. Global Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Global Prosthetic Joint Infections Treatment Sales Share by Type (2015-2020)
Table 62. Global Prosthetic Joint Infections Treatment Revenue by Type (2015-2020) (USD Million)
Table 63. Global Prosthetic Joint Infections Treatment Revenue Share by Type (2015-2020)
Table 64. Global Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 65. Global Prosthetic Joint Infections Treatment Sales Share by Application (2015-2020)
Table 66. Global Prosthetic Joint Infections Treatment Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Prosthetic Joint Infections Treatment Market Share Forecast by Regions (2021-2025)
Table 68. Global Prosthetic Joint Infections Treatment Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Prosthetic Joint Infections Treatment Market Share Forecast by Type (2021-2025)
Table 70. Global Prosthetic Joint Infections Treatment Sales Forecast by Application (2021-2025)
Table 71. Global Prosthetic Joint Infections Treatment Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prosthetic Joint Infections Treatment Picture
Figure 2. Global Sales Market Share of Prosthetic Joint Infections Treatment by Type in 2019
Figure 3. Fusidic acid Picture
Figure 4. Lefamulin Acetate Picture
Figure 5. MTF-101 Picture
Figure 6. TNP-2092 Picture
Figure 7. Others Picture
Figure 8. Prosthetic Joint Infections Treatment Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Prosthetic Joint Infections Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Prosthetic Joint Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Prosthetic Joint Infections Treatment Sales Market Share by Manufacturer in 2019
Figure 33. Global Prosthetic Joint Infections Treatment Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Prosthetic Joint Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Prosthetic Joint Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Prosthetic Joint Infections Treatment Revenue Market Share by Regions (2015-2020)
Figure 40. Global Prosthetic Joint Infections Treatment Revenue Market Share by Regions in 2018
Figure 41. North America Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
Figure 42. Europe Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
Figure 44. South America Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020)
Figure 46. North America Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Prosthetic Joint Infections Treatment Sales Market Share by Countries (2015-2020)
Figure 48. North America Prosthetic Joint Infections Treatment Sales Market Share by Countries in 2018
Figure 49. North America Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2018
Figure 51. United States Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2019
Figure 57. Germany Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Prosthetic Joint Infections Treatment Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Prosthetic Joint Infections Treatment Revenue Market Share by Regions 2019
Figure 65. China Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Prosthetic Joint Infections Treatment Sales Market Share by Countries in 2019
Figure 72. South America Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2019
Figure 73. Brazil Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Prosthetic Joint Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Prosthetic Joint Infections Treatment Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Prosthetic Joint Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Prosthetic Joint Infections Treatment Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Prosthetic Joint Infections Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Prosthetic Joint Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Prosthetic Joint Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Prosthetic Joint Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Prosthetic Joint Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Prosthetic Joint Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
壊死性皮膚感染症治療の世界市場 2020年 Market Overview The global Necrotizing Skin infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Necroti…- ナイセリア淋病感染症治療の世界市場 2020年 Market Overview The global Neisseria Gonorrhoeae Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ne…
- アシネトバクター感染症治療の世界市場 2020年 Market Overview The Acinetobacter Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場 2020年 Market Overview The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 髄膜炎菌感染症ワクチンの世界市場 2020年 Market Overview The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococca…